Dec 29, 2025 CagriSema represents the next evolution in medical weight loss - Novo Nordisk's branded combination of semaglutide 2.4mg and cagrilintide 2.4mg that produced 15-25% body weight loss in Phase 3 trials
Join our Diabetic Coverage Auto-Ship Program to have discount diabetic supplies shipped on a set schedule
Cardiovascular Protection 9
Hydroquinone and its analogues in dermatology - a potential health risk
The benefits and drawbacks of glutathione IV include rapid peak concentration within minutes, skin improvement in 37.5% of participants versus 18.7% placebo, and FDA approval as chemotherapy adjunct, while risks encompass adverse events in 32% of users, lack of FDA approval for skin lightening, and benefits fading after 6 months of discontinuation
The Bottom Line: A Sophisticated Tool GHK-Cu is a sophisticated biological signal that works best when: Sourced from reputable, verified pharmacies